Vasopril

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vasopril

What is Vasopril?

Vasopril is a pharmaceutical medication categorized as an ACE inhibitor (angiotensin-converting enzyme inhibitor). It is primarily used to manage conditions related to the cardiovascular system, specifically focusing on the regulation of blood pressure and the reduction of strain on the heart.

Mechanism of Action

The medication works by interfering with the body's production of angiotensin II, a potent chemical that causes muscles surrounding the blood vessels to contract. By inhibiting the enzyme responsible for creating this chemical, Vasopril helps blood vessels to remain more relaxed and dilated. This process results in:

  • Lowered Blood Pressure: Reduced resistance within the arteries allows blood to flow more easily.
  • Improved Heart Efficiency: The heart does not have to pump as hard to circulate blood throughout the body.
  • Fluid Balance: It can assist in reducing the salt and water retention often associated with heart-related conditions.

Primary Uses

Vasopril is commonly utilized in the following clinical contexts:

  • Hypertension: To assist in bringing high blood pressure down to more stable levels.
  • Heart Failure: To manage symptoms and improve the long-term functional capacity of the heart muscle.
  • Post-Myocardial Infarction: To support heart recovery and improve survival outcomes following a heart attack.
  • Diabetic Nephropathy: To help protect kidney function in patients with diabetes who exhibit signs of kidney stress.

As a systemic treatment, Vasopril is intended for long-term management of chronic cardiovascular health rather than as a temporary or acute intervention.

Regulatory References

  1. National Heart, Lung, and Blood Institute: NIH
  2. European Medicines Agency (EMA) assessment
  3. European Medicines Agency

What side effects are possible with Vasopril?

Possible Side Effects and Safety Information

Vasopril, containing Enalapril maleate, is associated with a range of officially documented adverse reactions classified by government regulatory authorities based on incidence and affected organ systems. These classifications define the drug's safety profile.


Frequency and Common Reactions

Adverse reactions are formally categorized from Very Common (ge 1/10) to Rare. The most frequently reported effects, classified as Very Common, include dizziness, cough, and asthenia (weakness). Effects classified as Common (ge 1/100 to <1/10) include headache, hypotension (low blood pressure), fatigue, nausea, and increases in serum potassium (hyperkalemia) and serum creatinine.


Serious Safety Constraints

Angioedema is a documented, potentially life-threatening serious reaction involving swelling of the face, lips, tongue, glottis, and/or larynx, which can occur at any point during treatment. The drug also carries a Serious Warning regarding use during the second and third trimesters of pregnancy, as it is associated with a risk of fetal injury and death, leading to a mandatory contraindication during this period.


Time-Related Patterns and Systemic Effects

Pronounced hypotension is more likely to occur at the start of therapy or during dose increases, particularly in certain patient groups. The official safety profile notes effects across various organ classes, including Vascular/Cardiac (e.g., hypotension, syncope), Respiratory (cough), and Renal (impaired function). Furthermore, patients with pre-existing renal impairment are noted as being at higher risk of experiencing severe hypotension and deterioration of kidney function.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Vasopril (Enalapril maleate) is officially characterized by profound hypotension, or an extreme drop in blood pressure, due to an excessive pharmacological effect. The documented clinical presentation includes symptoms such as severe dizziness, fainting (syncope), and an accelerated tachycardia (increased heart rate).


Severe Manifestations and Required Action

The principal regulatory concern is the risk of sustained hypotension leading to life-threatening complications, including circulatory shock and acute renal failure (kidney damage). For individuals with pre-existing vascular conditions, an excessive blood pressure fall may also result in a myocardial infarction or cerebrovascular accident. In the event of any suspected ingestion of Vasopril beyond the prescribed dose, immediate medical attention is required. Official guidance mandates contacting emergency services if the individual experiences syncope, seizures, or unresponsiveness.


Supportive Management

Management is symptomatic and supportive, as there is no specific pharmacological antidote cited in regulatory documents. Treatment involves procedural steps such as the intravenous infusion of saline to restore blood pressure. For severe overexposure, hemodialysis is documented as a procedure to effectively remove the active metabolite, Enalaprilat. Patients must undergo close hospital monitoring of vital signs and renal function.

Therapeutic Uses of Vasopril

What Vasopril Treats: Main Uses and Benefits

Vasopril is a prescription medication utilized in adults for the long-term management of elevated blood pressure (hypertension). By assisting in blood pressure control, the medication may help reduce the likelihood of certain serious cardiovascular events.

Vasopril is also a component in the management of chronic heart failure. In this setting, it helps in the relief of associated symptoms and supports improved heart function, particularly in patients experiencing fluid buildup. Furthermore, the drug is used following an acute myocardial infarction (heart attack) to support the heart's recovery process.

Vasopril is indicated for the treatment of essential hypertension, chronic heart failure, and post-myocardial infarction care.


Quick Fact: Relief for Heart Function Vasopril supports improved function in individuals managing chronic heart failure and aids in the heart's recovery process following a heart attack.

Eligibility and Restrictions for Use

Who Can and Cannot Use Vasopril?

The eligibility for Vasopril (Enalapril maleate) is strictly defined by official regulatory criteria, focusing on absolute contraindications and specific population limitations.

Mandatory Exclusions

Vasopril is contraindicated in patients with a history of angioedema, whether related to prior ACE inhibitor therapy or when the condition is hereditary or idiopathic. Use is also strictly prohibited during the second and third trimesters of pregnancy due to the documented risk of fetal injury and death. Additionally, patients with diabetes or renal impairment must not use Vasopril if they are also taking the drug aliskiren, nor should it be used with sacubitril/valsartan.

Age and Organ Function Restrictions

The medicine is approved for use in adults and children mathbf1 month of age and older for the treatment of hypertension. Use is not recommended in infants younger than mathbf1 month due to insufficient data. For adults with severe renal impairment, treatment requires specific caution and close monitoring. Similarly, the use in patients with hepatic impairment is labeled as requiring caution due to limited safety data documented in the official prescribing information.

What should I know about interactions with other medicines?

Vasopril Interactions with other medicines and products

Vasopril's interaction profile is defined by official restrictions and documented effects with specific product classes. Co-administration with Sacubitril/Valsartan is formally prohibited, requiring a mandatory 36-hour wash-out period between the last dose of Enalapril and the first dose of the ARNI combination.

Dual blockade of the Renin-Angiotensin-Aldosterone System (RAAS) is restricted: co-administration with Aliskiren is contraindicated in patients with diabetes mellitus or moderate to severe renal impairment (GFR less than 60 mL/min/1.73 m^2).

The risk of hyperkalemia is officially documented when Vasopril is combined with potassium-sparing diuretics or potassium-containing salt substitutes due to an additive effect on potassium retention. Furthermore, co-administration with Lithium leads to reduced renal clearance, resulting in increased serum concentrations of Lithium.

Interactions with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce the antihypertensive effect of Vasopril and carry a documented risk of renal function deterioration, particularly in elderly or volume-depleted individuals. Alcohol consumption may increase the hypotensive effects of Vasopril. The official label notes that the medication's absorption is not influenced by the presence of food in the gastrointestinal tract.

Mechanism of Action

Vasopril, a prodrug containing enalapril maleate, is rapidly converted in vivo via hydrolysis to its active metabolite, enalaprilat. Enalaprilat functions as a competitive inhibitor of the angiotensin-converting enzyme (ACE), a peptidyl dipeptidase.

ACE is the biological target primarily responsible for catalyzing the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II within the Renin-Angiotensin-Aldosterone System (RAAS).

Inhibition of ACE by enalaprilat results in a sharp reduction of circulating and tissue-localized angiotensin II concentrations. The molecular consequence of reduced angiotensin II is a decreased stimulation of the AT1 receptors on vascular smooth muscle, leading to vasodilation and a reduction in systemic vascular resistance. Furthermore, diminished angiotensin II levels result in reduced aldosterone secretion from the adrenal cortex, which modulates renal tubular reabsorption and promotes a minor natriuresis and fluid volume reduction. Inhibition of ACE also slows the degradation of the vasodilator peptide bradykinin, potentially contributing to the systemic vasodilation. The system-level physiological modulation is a reduction in peripheral resistance and an attenuation of cardiac workload.

Dosage and Administration Information

The administration of Vasopril (Enalapril maleate) follows established protocols regarding the route, dosing, and timing. The medication is delivered primarily as an oral tablet or oral solution, while its active metabolite, Enalaprilat, is an intravenous injection reserved for specialized hospital use.

Dosing follows standardized protocols for both initiation and maintenance. For hypertension, the typical starting dose is 5 mg once daily. The maintenance dose ranges from 10 to 40 mg daily, which may be taken as a single dose or divided into two daily doses. For heart failure, the initial dose is 2.5 mg once or twice daily, which involves close medical supervision during the start of therapy. The maximum daily dose across all indications is 40 mg.

The frequency pattern is typically once or twice daily, and the oral tablet may be taken with or without food as its absorption is not affected by meals. Treatment requires a gradual titration schedule, where the dose is slowly increased over several weeks to reach the final maintenance level. Special procedural conditions apply to specific patient groups: those with renal impairment typically start at a reduced dose (e.g., 2.5 mg once daily). In the event of a missed dose, standard practice involves omitting the missed dose and resuming the schedule at the next regularly scheduled time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vasopril

Evidence for Use in High Blood Pressure (Hypertension)

Research exploring Vasopril in the context of high blood pressure has primarily relied on Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies examined changes in both Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) over defined time intervals. The studies monitored mainly adults with newly identified or established high blood pressure.

Studies described measurements of SBP and DBP in the observed groups compared to those who received a placebo. Findings describe patterns observed in these studies regarding the proportion of participants who reached predefined blood pressure goals. However, results apply only to the populations studied, and research does not determine whether an individual will respond similarly.

The research provides context but not individual predictions regarding short-term changes in blood pressure. While research examined outcomes related to physiological strain or stress, certainty remains low for comprehensive, long-term event patterns based solely on these initial trials.

Long-Term Studies and Follow-Up Data

Research has also explored the effects of Vasopril over longer timeframes, primarily through observational cohort settings. These studies were designed to monitor physiological strain or stress over intervals lasting up to several years. Longer-term studies have reported patterns related to the long-term status of blood pressure measurements.

However, long-term effects are not fully established by the currently available RCTs. There is limited information for long-term outcomes that extends reliably beyond three to five years, which means the research provides only partial insight into outcomes over a patient's lifetime.

Evidence in Special Populations

Vasopril was evaluated in specific subgroups, including older adults (ge 65 years) and individuals presenting with conditions marked by functional limitations, such as those with mild to moderate kidney problems. Findings indicate patterns related to the monitored blood pressure outcomes within these special groups.

Despite this, data for certain groups remain insufficient. For instance, there is limited information available for women who are pregnant or planning to conceive, and subgroup findings are uncertain or based on modest sample sizes for very specific severe comorbidities.

Frequently Asked Questions (FAQ)

Common questions about Vasopril (FAQ)


Q: How long does it typically take to see the full effect of Vasopril?

According to official product information, the initial lowering of blood pressure may be seen within one hour of taking the tablet. The peak effect is generally achieved within four to six hours.

However, for the full, long-term therapeutic benefits to fully develop in the body, treatment often requires a period of several weeks.


Q: Is Vasopril considered a blood thinner?

Vasopril is a type of medicine known as an Angiotensin-Converting Enzyme (ACE) inhibitor. Its mechanism is described as promoting the relaxation and widening of blood vessels, which reduces blood pressure.

This function is different from that of a blood thinner (an anticoagulant or antiplatelet medicine), so Vasopril is not categorized as a blood thinner.


Q: Can Vasopril cause extreme tiredness or fatigue?

Official safety data indicates that both fatigue and asthenia (a medical term for weakness or lack of energy) are commonly reported side effects. The official safety profile notes that pronounced hypotension, which can lead to symptoms like fatigue, is more likely to occur at the start of therapy.


Q: Is Vasopril safe for use during pregnancy or while breastfeeding?

Use during the second and third trimesters of pregnancy is strictly prohibited due to documented risks to the fetus. Official information regarding breastfeeding notes that only very low levels of the medicine pass into breast milk.

The available data suggests that the amounts ingested by the infant are small, and significant adverse effects have not typically been observed.


Q: Can Vasopril be used by people who also have diabetes?

Vasopril is often used by patients with diabetes for blood pressure and heart conditions. Official safety information highlights that this population is noted as being particularly susceptible to developing high potassium levels (hyperkalemia).

Regulatory guidelines specify that close monitoring of blood chemistry is necessary in this population due to the elevated risk of hyperkalemia.


Q: How long does the effect of one dose of Vasopril typically last?

The active substance in the medicine has an effective half-life for accumulation of 11 hours once multiple doses have been taken. This half-life supports its typical administration frequency, which is described in the labeling as once or twice daily.


Q: What is the difference between Vasopril and an ARB medication?

Vasopril is an ACE inhibitor that acts by blocking the enzyme responsible for creating the hormone Angiotensin II. In contrast, Angiotensin II Receptor Blockers (ARBs) work by blocking the specific receptor in the body that Angiotensin II binds to.

Both types of medicine modulate the same hormonal system but target it at different points in the process.


Q: What happens if a person stops taking Vasopril suddenly?

Regulatory summaries indicate that, unlike some other blood pressure medicines, Vasopril is not highly associated with a risk of rebound hypertension upon sudden discontinuation.

Rebound hypertension is a dangerous rapid and severe rise in blood pressure.


Q: Is a metallic or strange taste in the mouth a known side effect of Vasopril?

Taste alteration (dysgeusia) is listed in the official documentation as an uncommon side effect. This means it is reported to occur in less than 1 in 100 people using the medication.


Q: What happens if Vasopril is taken with alcohol?

The official interactions documentation notes that consuming alcohol may increase the drug’s hypotensive effects (blood pressure lowering effects).

This increased effect can raise the risk of experiencing symptoms such as dizziness or light-headedness.


Q: Why do some people say they have trouble sleeping on Vasopril?

Official information lists insomnia (difficulty falling or staying asleep) as an uncommon side effect. More generally, sleep disorders are classified as a rare effect.

Some research also suggests a link between ACE inhibitors and the potential worsening of Obstructive Sleep Apnea (OSA) in some patients.


Q: Can Vasopril be used to prevent heart attack or stroke?

The official indication for its use in hypertension is to lower blood pressure, which is intended to reduce the risk of fatal and nonfatal cardiovascular events.

This includes the reduction of risk for strokes and myocardial infarctions (heart attacks).


Q: Can Vasopril cause headaches?

Yes, headache is an officially documented side effect of Vasopril. Regulatory tables classify headaches as a common side effect, meaning it is reported to occur in 1% to 10% of users.


Q: How is Vasopril different from other drugs ending in '-pril'?

Vasopril (enalapril) is classified as a prodrug, which means it is administered in an inactive form and must be converted by the body to its active component to be effective.

While all drugs ending in '-pril' are ACE inhibitors, they can differ in their exact chemical structure, how they are metabolized, and whether they are prodrugs.


Q: Are there any known severe, but rare, side effects of Vasopril?

While very uncommon, officially documented side effects classified as rare include serious skin conditions such as erythroderma and exfoliative dermatitis.

Severe blood disorders, such as a serious drop in white blood cells (agranulocytosis), are also listed as rare adverse reactions.


Q: Is Vasopril commonly prescribed for conditions other than high blood pressure?

The medication is officially approved for three primary indications. In addition to hypertension, these uses include the treatment of symptomatic heart failure and the management of asymptomatic left ventricular dysfunction.


Q: Is it normal for a healthcare provider to adjust the dose of Vasopril frequently at the start?

Regulatory guidelines describe the treatment initiation as requiring a gradual titration schedule to establish the correct dose. This process involves slowly increasing the dose over several weeks.

This process is designed to be slow, often involving check-ins and dose adjustments over several weeks to establish the maintenance level described in the labeling.


Q: What is the connection between Vasopril and high potassium (hyperkalemia)?

Vasopril works by suppressing the body's Renin-Angiotensin-Aldosterone System. This action results in decreased secretion of the hormone aldosterone.

Aldosterone is responsible for regulating potassium, so its decrease can lead to a reduced rate of potassium excretion by the kidneys, resulting in increased serum potassium levels.


Q: What is the risk of an allergic reaction that is not angioedema?

The official safety profile documents other allergic reactions separate from the serious swelling known as angioedema. These documented hypersensitivity reactions include a general rash and urticaria (hives), which are categorized as uncommon side effects.


Q: Does Vasopril have a risk of causing a skin rash?

Yes. Skin rash is listed as an officially documented side effect associated with the medication. This reaction is typically classified as uncommon, meaning it occurs in less than 1 in 100 users.

How should Vasopril be stored and disposed of?

How to Store and Dispose of Vasopril?

The official instructions for Vasopril (Enalapril maleate) tablets prioritize maintaining product stability and ensuring safe disposal, as required by regulatory bodies.


Storage Requirements

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be stored below 30 C to maintain stability.
  • Protection: The tablets must be protected from moisture and light. Do not store in high-humidity areas, such as a bathroom.
  • Container: Keep the medication in its original container and ensure the lid is tightly closed.
  • Safety: The product must be kept strictly out of the sight and reach of children and pets.

️ Disposal Instructions

  • Method: Do not dispose of unused or expired Vasopril via wastewater (flushing) or household trash.
  • Protocol: Return the medication to a pharmacist or an approved local drug take-back program for regulated disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vasopril found in:

A-Z Index: